MedPath

Using NI-ES to Treat Spinal Cord Injury (SCI)

Not Applicable
Conditions
Spinal Cord Injuries
Pain, Neuropathic
Registration Number
NCT04097015
Lead Sponsor
SCI Research Advancement
Brief Summary

NI-ES therapy is a treatment that is being studied to potentially treat pain associated with SCI and may help movement below the injury site.

Detailed Description

The overall goal of this study is to assess the use of externally applied micro-current electrical stimulation in a subject with SCI to reduce pain and patient perceived improvement of quality of life first, and second, movement below the SCI injury. The Hypothesis is that NI-ES is beneficial in reducing pain following SCI injury, patient perceived quality of life measures, and functional outcomes. We plan to achieve this goal by conducting a Pain Questionnaire and assessment of movement below the injury site prior to external micro-current electrical stimulation with the Spinal Stim (Alpha-Stim M with the Ocular Interface and the Spinal Interface) and again six weeks following the first treatment. These results will be used to characterize the extent and duration of any improvement in pain and movement as a result of treatment with the Spinal Stim.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1
Inclusion Criteria
  • Male or female
  • The presence of SCI
  • Pain associated with the SCI
  • Difficulty with body movement below the SCI
Exclusion Criteria
  • Absence of SCI
  • Poor health
  • Deemed unsuitable for participation by the Investigator.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Pain reduction measured by Pain Questionnaire6 weeks

Reduce neuropathic pain

Secondary Outcome Measures
NameTimeMethod
Functional movement as measured by the ASIA Motor Score6 weeks

Movement below the SCI

Trial Locations

Locations (1)

Home site

🇺🇸

Buellton, California, United States

Home site
🇺🇸Buellton, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.